Global Gene Therapy on Neurological Diseases Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Gene Therapy on Neurological Diseases Industry Forecast” looks at past sales and reviews total world Gene Therapy on Neurological Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy on Neurological Diseases sales for 2023 through 2029. With Gene Therapy on Neurological Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy on Neurological Diseases industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy on Neurological Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy on Neurological Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy on Neurological Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy on Neurological Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy on Neurological Diseases.
The global Gene Therapy on Neurological Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy on Neurological Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy on Neurological Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy on Neurological Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy on Neurological Diseases players cover Biogen, Novartis and Sarepta Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy on Neurological Diseases market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Gene Therapy on Neurological Diseases Industry Forecast” looks at past sales and reviews total world Gene Therapy on Neurological Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy on Neurological Diseases sales for 2023 through 2029. With Gene Therapy on Neurological Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy on Neurological Diseases industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy on Neurological Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy on Neurological Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy on Neurological Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy on Neurological Diseases and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy on Neurological Diseases.
The global Gene Therapy on Neurological Diseases market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapy on Neurological Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapy on Neurological Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapy on Neurological Diseases is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapy on Neurological Diseases players cover Biogen, Novartis and Sarepta Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy on Neurological Diseases market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Viral Gene Therapy
- Non-viral Gene Therapy
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Sarepta Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy on Neurological Diseases Market Size 2018-2029
2.1.2 Gene Therapy on Neurological Diseases Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy on Neurological Diseases Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.3 Gene Therapy on Neurological Diseases Market Size by Type
2.3.1 Gene Therapy on Neurological Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy on Neurological Diseases Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gene Therapy on Neurological Diseases Market Size by Application
2.5.1 Gene Therapy on Neurological Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
3 GENE THERAPY ON NEUROLOGICAL DISEASES MARKET SIZE BY PLAYER
3.1 Gene Therapy on Neurological Diseases Market Size Market Share by Players
3.1.1 Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy on Neurological Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY ON NEUROLOGICAL DISEASES BY REGIONS
4.1 Gene Therapy on Neurological Diseases Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
4.3 APAC Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
4.4 Europe Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
5.2 Americas Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
5.3 Americas Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy on Neurological Diseases Market Size by Region (2018-2023)
6.2 APAC Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
6.3 APAC Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy on Neurological Diseases by Country (2018-2023)
7.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
7.3 Europe Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy on Neurological Diseases by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY ON NEUROLOGICAL DISEASES MARKET FORECAST
10.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy on Neurological Diseases Forecast
10.1.3 APAC Gene Therapy on Neurological Diseases Forecast
10.1.4 Europe Gene Therapy on Neurological Diseases Forecast
10.1.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast
10.2 Americas Gene Therapy on Neurological Diseases Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy on Neurological Diseases Market Forecast
10.2.2 Canada Gene Therapy on Neurological Diseases Market Forecast
10.2.3 Mexico Gene Therapy on Neurological Diseases Market Forecast
10.2.4 Brazil Gene Therapy on Neurological Diseases Market Forecast
10.3 APAC Gene Therapy on Neurological Diseases Forecast by Region (2024-2029)
10.3.1 China Gene Therapy on Neurological Diseases Market Forecast
10.3.2 Japan Gene Therapy on Neurological Diseases Market Forecast
10.3.3 Korea Gene Therapy on Neurological Diseases Market Forecast
10.3.4 Southeast Asia Gene Therapy on Neurological Diseases Market Forecast
10.3.5 India Gene Therapy on Neurological Diseases Market Forecast
10.3.6 Australia Gene Therapy on Neurological Diseases Market Forecast
10.4 Europe Gene Therapy on Neurological Diseases Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy on Neurological Diseases Market Forecast
10.4.2 France Gene Therapy on Neurological Diseases Market Forecast
10.4.3 UK Gene Therapy on Neurological Diseases Market Forecast
10.4.4 Italy Gene Therapy on Neurological Diseases Market Forecast
10.4.5 Russia Gene Therapy on Neurological Diseases Market Forecast
10.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy on Neurological Diseases Market Forecast
10.5.2 South Africa Gene Therapy on Neurological Diseases Market Forecast
10.5.3 Israel Gene Therapy on Neurological Diseases Market Forecast
10.5.4 Turkey Gene Therapy on Neurological Diseases Market Forecast
10.5.5 GCC Countries Gene Therapy on Neurological Diseases Market Forecast
10.6 Global Gene Therapy on Neurological Diseases Forecast by Type (2024-2029)
10.7 Global Gene Therapy on Neurological Diseases Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy on Neurological Diseases Product Offered
11.1.3 Biogen Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy on Neurological Diseases Product Offered
11.2.3 Novartis Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Information
11.3.2 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Offered
11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sarepta Therapeutics Main Business Overview
11.3.5 Sarepta Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy on Neurological Diseases Market Size 2018-2029
2.1.2 Gene Therapy on Neurological Diseases Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene Therapy on Neurological Diseases Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.3 Gene Therapy on Neurological Diseases Market Size by Type
2.3.1 Gene Therapy on Neurological Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
2.4 Gene Therapy on Neurological Diseases Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gene Therapy on Neurological Diseases Market Size by Application
2.5.1 Gene Therapy on Neurological Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
3 GENE THERAPY ON NEUROLOGICAL DISEASES MARKET SIZE BY PLAYER
3.1 Gene Therapy on Neurological Diseases Market Size Market Share by Players
3.1.1 Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2018-2023)
3.2 Global Gene Therapy on Neurological Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY ON NEUROLOGICAL DISEASES BY REGIONS
4.1 Gene Therapy on Neurological Diseases Market Size by Regions (2018-2023)
4.2 Americas Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
4.3 APAC Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
4.4 Europe Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)
5.2 Americas Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
5.3 Americas Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy on Neurological Diseases Market Size by Region (2018-2023)
6.2 APAC Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
6.3 APAC Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy on Neurological Diseases by Country (2018-2023)
7.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
7.3 Europe Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy on Neurological Diseases by Region (2018-2023)
8.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY ON NEUROLOGICAL DISEASES MARKET FORECAST
10.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2024-2029)
10.1.1 Global Gene Therapy on Neurological Diseases Forecast by Regions (2024-2029)
10.1.2 Americas Gene Therapy on Neurological Diseases Forecast
10.1.3 APAC Gene Therapy on Neurological Diseases Forecast
10.1.4 Europe Gene Therapy on Neurological Diseases Forecast
10.1.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast
10.2 Americas Gene Therapy on Neurological Diseases Forecast by Country (2024-2029)
10.2.1 United States Gene Therapy on Neurological Diseases Market Forecast
10.2.2 Canada Gene Therapy on Neurological Diseases Market Forecast
10.2.3 Mexico Gene Therapy on Neurological Diseases Market Forecast
10.2.4 Brazil Gene Therapy on Neurological Diseases Market Forecast
10.3 APAC Gene Therapy on Neurological Diseases Forecast by Region (2024-2029)
10.3.1 China Gene Therapy on Neurological Diseases Market Forecast
10.3.2 Japan Gene Therapy on Neurological Diseases Market Forecast
10.3.3 Korea Gene Therapy on Neurological Diseases Market Forecast
10.3.4 Southeast Asia Gene Therapy on Neurological Diseases Market Forecast
10.3.5 India Gene Therapy on Neurological Diseases Market Forecast
10.3.6 Australia Gene Therapy on Neurological Diseases Market Forecast
10.4 Europe Gene Therapy on Neurological Diseases Forecast by Country (2024-2029)
10.4.1 Germany Gene Therapy on Neurological Diseases Market Forecast
10.4.2 France Gene Therapy on Neurological Diseases Market Forecast
10.4.3 UK Gene Therapy on Neurological Diseases Market Forecast
10.4.4 Italy Gene Therapy on Neurological Diseases Market Forecast
10.4.5 Russia Gene Therapy on Neurological Diseases Market Forecast
10.5 Middle East & Africa Gene Therapy on Neurological Diseases Forecast by Region (2024-2029)
10.5.1 Egypt Gene Therapy on Neurological Diseases Market Forecast
10.5.2 South Africa Gene Therapy on Neurological Diseases Market Forecast
10.5.3 Israel Gene Therapy on Neurological Diseases Market Forecast
10.5.4 Turkey Gene Therapy on Neurological Diseases Market Forecast
10.5.5 GCC Countries Gene Therapy on Neurological Diseases Market Forecast
10.6 Global Gene Therapy on Neurological Diseases Forecast by Type (2024-2029)
10.7 Global Gene Therapy on Neurological Diseases Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy on Neurological Diseases Product Offered
11.1.3 Biogen Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy on Neurological Diseases Product Offered
11.2.3 Novartis Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Information
11.3.2 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Offered
11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sarepta Therapeutics Main Business Overview
11.3.5 Sarepta Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy on Neurological Diseases Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-viral Gene Therapy
Table 4. Gene Therapy on Neurological Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy on Neurological Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy on Neurological Diseases Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy on Neurological Diseases Key Players Head office and Products Offered
Table 13. Gene Therapy on Neurological Diseases Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy on Neurological Diseases Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy on Neurological Diseases Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy on Neurological Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy on Neurological Diseases Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy on Neurological Diseases
Table 45. Key Market Challenges & Risks of Gene Therapy on Neurological Diseases
Table 46. Key Industry Trends of Gene Therapy on Neurological Diseases
Table 47. Global Gene Therapy on Neurological Diseases Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy on Neurological Diseases Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy on Neurological Diseases Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors
Table 52. Biogen Gene Therapy on Neurological Diseases Product Offered
Table 53. Biogen Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors
Table 57. Novartis Gene Therapy on Neurological Diseases Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Sarepta Therapeutics Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors
Table 62. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Offered
Table 63. Sarepta Therapeutics Main Business
Table 64. Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Sarepta Therapeutics Latest Developments
Table 1. Gene Therapy on Neurological Diseases Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-viral Gene Therapy
Table 4. Gene Therapy on Neurological Diseases Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 7. Gene Therapy on Neurological Diseases Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 10. Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene Therapy on Neurological Diseases Revenue Market Share by Player (2018-2023)
Table 12. Gene Therapy on Neurological Diseases Key Players Head office and Products Offered
Table 13. Gene Therapy on Neurological Diseases Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene Therapy on Neurological Diseases Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene Therapy on Neurological Diseases Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene Therapy on Neurological Diseases Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene Therapy on Neurological Diseases Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene Therapy on Neurological Diseases
Table 45. Key Market Challenges & Risks of Gene Therapy on Neurological Diseases
Table 46. Key Industry Trends of Gene Therapy on Neurological Diseases
Table 47. Global Gene Therapy on Neurological Diseases Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene Therapy on Neurological Diseases Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene Therapy on Neurological Diseases Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors
Table 52. Biogen Gene Therapy on Neurological Diseases Product Offered
Table 53. Biogen Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors
Table 57. Novartis Gene Therapy on Neurological Diseases Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Sarepta Therapeutics Details, Company Type, Gene Therapy on Neurological Diseases Area Served and Its Competitors
Table 62. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Offered
Table 63. Sarepta Therapeutics Main Business
Table 64. Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Sarepta Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy on Neurological Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy on Neurological Diseases Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy on Neurological Diseases Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy on Neurological Diseases Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy on Neurological Diseases Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy on Neurological Diseases Market Size Market Share by Type in 2022
Figure 10. Gene Therapy on Neurological Diseases in Hospital
Figure 11. Global Gene Therapy on Neurological Diseases Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Gene Therapy on Neurological Diseases in Clinic
Figure 13. Global Gene Therapy on Neurological Diseases Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Gene Therapy on Neurological Diseases in Other
Figure 15. Global Gene Therapy on Neurological Diseases Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2022
Figure 17. Global Gene Therapy on Neurological Diseases Revenue Market Share by Player in 2022
Figure 18. Global Gene Therapy on Neurological Diseases Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene Therapy on Neurological Diseases Value Market Share by Country in 2022
Figure 24. United States Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Region in 2022
Figure 29. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Type in 2022
Figure 30. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2022
Figure 31. China Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Country in 2022
Figure 38. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 61. China Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 65. India Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 68. France Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene Therapy on Neurological Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy on Neurological Diseases Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene Therapy on Neurological Diseases Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene Therapy on Neurological Diseases Sales Market Share by Country/Region (2022)
Figure 8. Gene Therapy on Neurological Diseases Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene Therapy on Neurological Diseases Market Size Market Share by Type in 2022
Figure 10. Gene Therapy on Neurological Diseases in Hospital
Figure 11. Global Gene Therapy on Neurological Diseases Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Gene Therapy on Neurological Diseases in Clinic
Figure 13. Global Gene Therapy on Neurological Diseases Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Gene Therapy on Neurological Diseases in Other
Figure 15. Global Gene Therapy on Neurological Diseases Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2022
Figure 17. Global Gene Therapy on Neurological Diseases Revenue Market Share by Player in 2022
Figure 18. Global Gene Therapy on Neurological Diseases Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene Therapy on Neurological Diseases Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene Therapy on Neurological Diseases Value Market Share by Country in 2022
Figure 24. United States Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Region in 2022
Figure 29. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Type in 2022
Figure 30. APAC Gene Therapy on Neurological Diseases Market Size Market Share by Application in 2022
Figure 31. China Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Country in 2022
Figure 38. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene Therapy on Neurological Diseases Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 61. China Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 65. India Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 68. France Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene Therapy on Neurological Diseases Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene Therapy on Neurological Diseases Market Size Market Share Forecast by Application (2024-2029)
